Presentation Information
[P1-06-4]Efficacy and safety of selumetinib on plexiform neurofibroma in patients with neurofibromatosis type 1: mid-term results
○Yoshihiro Nishida1, Norie Nonobe2, Hiroyuki Kidokoro2,3, Taichi Kato3, Kunihiro Ikuta4, Shiro Imagama4 (1.Department of Rehabilitation Medicine, Nagoya University Hospital, Nagoya, Japan, 2.Department of Ophthalmology, Nagoya University Graduate School of Medicine, 3.Department of Pediatrics, Nagoya University Graduate School of Medicine, 4.Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine)